Filing Details

Accession Number:
0001214659-21-006695
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-06-17 16:31:07
Reporting Period:
2021-06-15
Accepted Time:
2021-06-17 16:31:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1677077 Alzamend Neuro Inc. ALZN () DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1212502 Iii C Milton Ault 3802 Spectrum Boulevard, Suite 112C
Tampa FL 33612
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-06-15 2,000,000 $5.00 5,094,555 No 4 P Indirect By Digital Power Lending, LLC
Common Stock Acquisiton 2021-06-17 15,000,000 $0.00 15,000,000 No 4 C Indirect By Ault Life Sciences, Inc.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Digital Power Lending, LLC
No 4 C Indirect By Ault Life Sciences, Inc.
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Convertible Preferred Stock Disposition 2021-06-17 750,000 $0.00 15,000,000 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 10,000,000 Indirect By Ault Life Sciences Fund, LLC
Footnotes
  1. Digital Power Lending, LLC ("DPL") is a wholly-owned subsidiary of Ault Global Holdings, Inc. ("AGH"). Mr. Ault, the Executive Chairman of AGH, is deemed to have voting and investment power with respect to the securities held of record by DPL.
  2. The 15,000,000 shares of Common Stock were issued to Ault Life Sciences, Inc. ("ALS") upon the conversion of the 750,000 shares of the Issuer's Series A Convertible Preferred Stock (the "Series A Preferred Stock") owned by ALS, which conversion occurred automatically upon the closing of the Issuer's initial public offering without payment of further consideration. Mr. Ault has sole voting and investment power with respect to the shares of Series A Preferred Stock held of record by ALS.
  3. Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences Fund, LLC.